Shamburg News · 8-K filed Nov 5, 2026, 4:08 PM EST
Guardant Health Reports Third Quarter 2026 Results and Raises 2026 Revenue Guidance
GH · Guardant Health, Inc.
- Earnings
- Financial statements
- Materiality: high
Guardant Health reported third quarter 2026 revenue of $361.0 million, up 36% from the prior year period, and a net loss of $124.4 million, or $0.93 per share. Non-GAAP net loss per share was $0.29 for the quarter. The company raised its full-year 2026 revenue guidance to $1.36 to $1.37 billion from $1.34 to $1.36 billion.
Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001576280-26-000043.
Written from the filing by Shamburg Markets. Figures are as reported by the company.